• MOG (35-55): Mechanisms and Strategy for Next-Gen Autoimmune

  2026-07-02

  This thought-leadership article unpacks the mechanistic underpinnings and translational strategies for leveraging MOG (35-55)—a benchmark myelin oligodendrocyte glycoprotein peptide—in autoimmune encephalomyelitis research. Drawing on recent advances in interferon signaling regulation, we contextualize the peptide’s value in reproducible neuroinflammation assays and outline best practices for researchers seeking to model or modulate multiple sclerosis-like disease. The piece distinguishes itself by integrating new insights on PARP7-mediated post-translational control, offering a strategic roadmap for translational scientists.

• Temafloxacin: Broad-Spectrum Antibacterial Agent for Advance

  2026-07-01

  Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, empowers researchers with potent activity across Gram-positive and Gram-negative bacteria and unique efficacy in intracellular and respiratory infection models. This guide translates core bench protocols, experimental enhancements, and troubleshooting strategies, bridging cutting-edge reference findings into actionable laboratory optimization.

• Ceftolozane Sulfate for PK/PD and Susceptibility Testing Exc

  2026-07-01

  Ceftolozane sulfate empowers researchers to dissect resistant Pseudomonas aeruginosa with precision, thanks to its robust PBP3 targeting and β-lactamase stability. This article explores optimized protocols, advanced PK/PD modeling, and troubleshooting strategies that set new standards in in vitro and in vivo antibacterial research.

• Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Endocy

  2026-06-30

  This study provides the first mechanistic insights into how Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, identifying clathrin-mediated endocytosis and macropinocytosis as essential pathways. The work informs both invertebrate host-pathogen research and experimental approaches for dissecting cellular entry and cytoskeletal dependencies.

• DNMT Inhibition Restores cGAS-STING and Activates RIG-I/MDA5

  2026-06-30

  This study demonstrates that DNMT inhibitors can epigenetically reactivate the cGAS-STING pathway and trigger RIG-I/MDA5-MAVS signaling, enhancing antitumor immunity in breast cancer models. These findings highlight the potential of combining epigenetic modulation with conventional therapies to restore innate immune responses and improve immunotherapy outcomes.

• Sisomicin and Translational Strategies Against MDR Pathogens

  2026-06-29

  This thought-leadership article explores Sisomicin’s mechanistic and strategic value in modern translational research, providing actionable insights for combating multidrug-resistant bacteria. By integrating biological rationale, experimental best practices, competitive positioning, and a forward-looking outlook, this piece serves as both a scientific primer and a strategic guide for researchers navigating the evolving landscape of antibiotic resistance.

• Vancomycin Hydrochloride: Innovations in Selective Microbiol

  2026-06-29

  Explore how Vancomycin hydrochloride accelerates selective microbiology and antibiotic resistance research. This article reveals unique protocol insights and novel applications in veterinary and translational science.

• Pandemic Response Box Screening Identifies Novel Antibacteri

  2026-06-28

  This study systematically screened the MMV Pandemic Response Box to identify compounds with potent in vitro activity against multidrug-resistant (MDR) clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and several pathogenic fungi. The results highlight new antibacterial and antifungal candidates, providing a valuable resource for researchers addressing antimicrobial resistance.

• Sisomicin (SKU BA1199): Reliable Antibacterial Assay Perform

  2026-06-27

  This article guides biomedical researchers through real-world scenarios where Sisomicin (SKU BA1199) from APExBIO enhances the reliability and reproducibility of in vitro antibacterial assays. By addressing protocol optimization, cross-resistance pitfalls, and product selection, it provides evidence-based best practices for using this aminoglycoside antibiotic in Gram-negative and Gram-positive bacterial infection research.

• Alfuzosin Hydrochloride (SKU A5173): Reliable Solutions for

  2026-06-26

  This scenario-driven guide demonstrates how Alfuzosin Hydrochloride (SKU A5173) addresses key challenges in benign prostatic hyperplasia research. With evidence-backed protocols and practical advice, researchers will discover why SKU A5173 from APExBIO stands out for assay reproducibility, sensitivity, and workflow efficiency.

• Carbapenemase Gene Dynamics in CREC from Guangdong Hospitals

  2026-06-26

  This multicenter study illuminates the prevalence, genetic diversity, and transmission mechanisms of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, China. The findings reveal a predominance of plasmid-borne blaNDM-1 and highlight the critical challenge of multidrug resistance and gene dissemination within clinical settings.

• Meropenem in Translational Septicemia Models: Mechanistic In

  2026-06-25

  Explore the advanced application of Meropenem, a β-lactam antibiotic carbapenem, in translational research on septicemia and resistant bacterial infections. This article delivers mechanistic depth and assay decision guidance not found in standard workflow guides.

• Sodium Dicloxacillin Monohydrate: Precision Tools for MSSA R

  2026-06-25

  Sodium dicloxacillin monohydrate enables reproducible, quantifiable inhibition of methicillin-sensitive Staphylococcus aureus (MSSA) in both cellular and animal models. This article delivers actionable protocol upgrades, troubleshooting guidance, and translational insights, positioning the compound as an advanced research tool for Gram-positive bacterial infection workflows.

• Standardized Amplex Red Assay for Autotaxin Inhibitor Screen

  2026-06-24

  Stylianaki et al. introduce a robust in vitro protocol leveraging the Amplex Red assay to quantify the efficacy of autotaxin (ATX) inhibitors, enabling reproducible screening, kinetic analysis, and minimization of false positives. This advancement aids preclinical discovery and characterization of novel ATX modulators targeting fibrotic and oncologic diseases.

• CF10 and EdU Synergy Induces Telomere Attrition in CRC Cells

  2026-06-23

  The referenced study demonstrates that combining the fluoropyrimidine polymer CF10 with 5-ethynyl-2′-deoxyuridine (EdU) induces marked telomere attrition and mitotic catastrophe in colorectal cancer cells, surpassing the effects of traditional 5-fluorouracil regimens. This synergistic mechanism provides a new avenue for therapeutic strategies targeting telomerase and telomere integrity in oncology research.

456 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page